Drugs / Td vaccine SSI
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01033877 Comparator | Jan → Aug 2010 | — | Statens Serum Institut | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Td vaccine SSI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01033877 ↗ |
| Known as | Td vaccine | “The clinical trial is a phase III, double-blind, randomised, controlled, multi-centre, clinical trial, on the immunogenicity and safety of TdaP vaccine in comparison to Td...” NCT01033877 ↗ |
| Modality | Vaccine | “a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults” PMID 22776216 ↗ Jul 2012 |